Martin J Raftery
Overview
Explore the profile of Martin J Raftery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boulifa A, Raftery M, Franzen A, Radecke C, Stintzing S, Blohmer J, et al.
BMC Cancer
. 2024 Mar;
24(1):339.
PMID: 38486205
Background: Beta-(1,3)(1,6)-D-glucan is a complex polysaccharide, which is found in the cell wall of various fungi, yeasts, bacteria, algae, barley, and oats and has immunomodulatory, anticancer and antiviral effects. In...
2.
Franzen A, Boulifa A, Radecke C, Stintzing S, Raftery M, Pecher G
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254876
Colorectal carcinoma (CRC) presents a formidable medical challenge, demanding innovative therapeutic strategies. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising alternative to CAR T-cell...
3.
Abdelaziz M, Raftery M, Weihs J, Bielawski O, Edel R, Koppke J, et al.
Front Immunol
. 2023 Jul;
14:1166765.
PMID: 37520530
Introduction: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the danger posed by human coronaviruses. Rapid emergence of immunoevasive variants and...
4.
Raftery M, Franzen A, Radecke C, Boulifa A, Schonrich G, Stintzing S, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240385
There is a medical need to develop new and effective therapies against triple-negative breast cancer (TNBC). Chimeric antigen receptor (CAR) natural killer (NK) cells are a promising alternative to CAR-T...
5.
Schonrich G, Abdelaziz M, Raftery M
Front Immunol
. 2022 Oct;
13:1028972.
PMID: 36275700
Multiple Sclerosis (MS) is an autoimmune disease that is characterized by inflammation and demyelination of nerve cells. There is strong evidence that Epstein-Barr virus (EBV), a human herpesvirus infecting B...
6.
Franzen A, Raftery M, Pecher G
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35804950
Breast cancer is poorly immunogenic due to immunosuppressive mechanisms produced in part by the tumor microenvironment (TME). The TME is a peritumoral area containing significant quantities of (1) cancer-associated fibroblasts...
7.
Schmidt P, Raftery M, Pecher G
Front Immunol
. 2021 Jan;
11:611163.
PMID: 33488617
The development of chimeric antigen receptor (CAR) T cell therapy has introduced a new and effective strategy to guide and promote the immune response against tumors in the clinic. More...
8.
Hartel H, Theiss J, Abdelaziz M, Raftery M, Pecher G, Bogner E
Viruses
. 2021 Jan;
13(1).
PMID: 33435377
Human cytomegalovirus (HCMV) has been implicated in the development of human malignancies, for instance in colon cancer. Proteasome inhibitors were developed for cancer therapy and have also been shown to...
9.
Schonrich G, Raftery M, Samstag Y
Adv Biol Regul
. 2020 Aug;
77:100741.
PMID: 32773102
Pandemic coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and poses an unprecedented challenge to healthcare systems due to the lack of a vaccine...
10.
Raftery M, Lalwani P, Lutteke N, Kobak L, Giese T, Ulrich R, et al.
Front Cell Infect Microbiol
. 2020 Jun;
10:281.
PMID: 32596167
Members of different virus families including cause viral hemorrhagic fevers (VHFs). The decisive determinants of hantavirus-associated pathogenicity are still enigmatic. Pathogenic hantavirus species, such as Puumala virus (PUUV), Hantaan virus...